CAS 181816-48-8: Ombrabulin
Description:Ombrabulin, with the CAS number 181816-48-8, is a synthetic compound that has been investigated for its potential as an anti-cancer agent. It functions primarily as a vascular disrupting agent, targeting the blood vessels that supply tumors, thereby inhibiting their growth and promoting tumor cell death. Ombrabulin is characterized by its ability to disrupt the formation of new blood vessels (angiogenesis) and induce apoptosis in cancer cells. The compound has been studied in various preclinical and clinical settings, particularly in relation to solid tumors. Its mechanism of action involves interference with the microtubule dynamics, which are crucial for cell division and the structural integrity of cells. While promising in early studies, the clinical efficacy and safety profile of Ombrabulin continue to be evaluated through ongoing research. As with many investigational drugs, understanding its pharmacokinetics, potential side effects, and interactions with other therapies is essential for its development in cancer treatment.
Formula:C21H26N2O6
InChI:InChI=1S/C21H26N2O6/c1-26-17-8-7-13(9-16(17)23-21(25)15(22)12-24)5-6-14-10-18(27-2)20(29-4)19(11-14)28-3/h5-11,15,24H,12,22H2,1-4H3,(H,23,25)/b6-5-/t15-/m0/s1
InChI key:InChIKey=IXWNTLSTOZFSCM-YVACAVLKSA-N
SMILES:O=C(NC1=CC(=CC=C1OC)C=CC2=CC(OC)=C(OC)C(OC)=C2)C(N)CO
- Synonyms:
- (2S)-2-Amino-3-hydroxy-N-[2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide
- Propanamide, 2-amino-3-hydroxy-N-[2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]-, (2S)-
- Propanamide, 2-amino-3-hydroxy-N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]-, [S-(Z)]-
- Ombrabulin
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Ombrabulin REF: TM-T16387CAS: 181816-48-8 | 98% | 44.00 € | Fri 21 Mar 25 |
![]() | Propanamide, 2-amino-3-hydroxy-N-[2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]-, (2S)- REF: IN-DA00233UCAS: 181816-48-8 | 98.00% | To inquire | Tue 25 Mar 25 |
![]() | Ombrabulin REF: TR-O633403CAS: 181816-48-8 | - - - | 9,788.00 € | Mon 05 May 25 |
![]() | Ombrabulin REF: 3D-GHA81648CAS: 181816-48-8 | Min. 95% | - - - | Discontinued product |

Ombrabulin
Ref: TM-T16387
1mg | 44.00 € |

Propanamide, 2-amino-3-hydroxy-N-[2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]-, (2S)-
Ref: IN-DA00233U
5mg | 297.00 € | ||
10mg | 626.00 € | ||
25mg | To inquire |

Ombrabulin
Controlled ProductRef: TR-O633403
250mg | 9,788.00 € |

Ombrabulin
Ref: 3D-GHA81648
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |